The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Provides functions for planning clinical trials subject to a delayed treatment effect using assurance-based methods. Includes two 'shiny' applications for interactive exploration, simulation, and visualisation of trial designs and outcomes. The methodology is described in: Salsbury JA, Oakley JE, Julious SA, Hampson LV (2024) "Assurance methods for designing a clinical trial with a delayed treatment effect" <doi:10.1002/sim.10136>, Salsbury JA, Oakley JE, Julious SA, Hampson LV (2024) "Adaptive clinical trial design with delayed treatment effects using elicited prior distributions" <doi:10.48550/arXiv.2509.07602>.
Version: | 1.0.0 |
Depends: | R (≥ 4.0) |
Imports: | SHELF, shiny, stats, survival, nleqslv, nph, nphRCT, dplyr, rjags, rpact, magrittr, rlang, future.apply |
Suggests: | testthat (≥ 3.0.0) |
Published: | 2025-10-14 |
DOI: | 10.32614/CRAN.package.DTEAssurance |
Author: | James Salsbury |
Maintainer: | James Salsbury <jsalsbury1 at sheffield.ac.uk> |
License: | MIT + file LICENSE |
URL: | https://jamesalsbury.github.io/DTEAssurance/ |
NeedsCompilation: | no |
Materials: | README, NEWS |
CRAN checks: | DTEAssurance results |
Reference manual: | DTEAssurance.html , DTEAssurance.pdf |
Package source: | DTEAssurance_1.0.0.tar.gz |
Windows binaries: | r-devel: DTEAssurance_1.0.0.zip, r-release: DTEAssurance_1.0.0.zip, r-oldrel: DTEAssurance_1.0.0.zip |
macOS binaries: | r-release (arm64): DTEAssurance_1.0.0.tgz, r-oldrel (arm64): DTEAssurance_1.0.0.tgz, r-release (x86_64): DTEAssurance_1.0.0.tgz, r-oldrel (x86_64): DTEAssurance_1.0.0.tgz |
Please use the canonical form https://CRAN.R-project.org/package=DTEAssurance to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.